DDSV Read More Intuit (INTU) Q1 2027 Earnings Call Transcript2026-11-21 ]]> Image source: The Motley Fool. DATE Nov. 19, 2026 CALL PARTICIPANTSVice President of Investor Relations – Kendra…
DDSV Read More Why Intuit stock is trading lower today2026-11-21 What happened? Shares of financial technology platform Intuit (NASDAQ:INTU) fell 9.4% in the pre-market session after the company…
NNovo Nordisk Read More Can New Products and Acquisitions Revive Pfizer’s Growth Story?2026-11-19 Pfizer’s PFE business mix has changed significantly over the past few years. During the pandemic, the company became…
NNovo Nordisk Read More Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue2026-11-18 Key Points Johnson & Johnson currently exhibits a stronger overall position by generating a substantially larger total revenue…
NNovo Nordisk Read More Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue2026-11-18 Key Points Johnson & Johnson currently exhibits a stronger overall position by generating a substantially larger total revenue…
NNovo Nordisk Read More Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue2026-11-17 Key Points Johnson & Johnson currently exhibits a stronger overall position by generating a substantially larger total revenue…
NNovo Nordisk Read More Can LLY’s Expanding Obesity Pipeline Sustain Its GLP-1 Leadership?2026-11-13 Eli Lilly and Company LLY has established itself as a dominant player in the rapidly expanding obesity treatment…
NNovo Nordisk Read More Can LLY’s Expanding Obesity Pipeline Sustain Its GLP-1 Leadership?2026-11-12 Eli Lilly and Company LLY has established itself as a dominant player in the rapidly expanding obesity treatment…
NNovo Nordisk Read More Eli Lilly vs Novo Nordisk: What’s the Better GLP-1 Stock to Buy?2026-11-10 Key Points Eli Lilly has been generating incredible growth in recent quarters due to its top GLP-1 drugs.…
NNovo Nordisk Read More Eli Lilly vs Novo Nordisk: What’s the Better GLP-1 Stock to Buy?2026-11-10 Key Points Eli Lilly has been generating incredible growth in recent quarters due to its top GLP-1 drugs.…
NNovo Nordisk Read More 3 Dirt Cheap Dividend Stocks to Buy in November 20262026-11-03 Key Points AT&T, Novo Nordisk, and Vici Properties have struggled this year but remain high-quality investments. Their valuations…
NNovo Nordisk Read More Novo Has Big Plans for 2030. Should You Buy the Stock Now?2026-10-29 Key Points Novo plans to expand its lineup and pipeline by 2030, while serving far more patients. The…